Kandera Reinhard 4
4 · HOOKIPA Pharma Inc. · Filed Apr 18, 2023
Insider Transaction Report
Form 4
Kandera Reinhard
DirectorChief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-04-14+214,800→ 214,800 totalExercise: $1.00Exp: 2033-04-14→ Common Stock (214,800 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on February 15, 2024, with the remainder vesting in 12 equal quarterly installments thereafter.